Statistical flag only — not an accusation of fraud
⚠️ This provider averages 1.1K services per working day — physically unusual for an individual practitioner
Based on 2.7M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $34.6M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.1K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 70% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 70/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 75% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $63.77 | $15.62 | 4.08x | $48.15 | $2.0M | 129.1K | 55 |
| 2015 | $61.70 | $16.28 | 3.79x | $45.42 | $2.3M | 144.2K | 56 |
| 2016 | $59.46 | $16.12 | 3.69x | $43.34 | $4.1M | 254.6K | 60 |
| 2017 | $75.62 | $19.03 | 3.97x | $56.59 | $4.4M | 230.6K | 66 |
| 2018 | $47.84 | $10.64 | 4.50x | $37.20 | $2.9M | 276.1K | 72 |
| 2019 | $51.11 | $11.15 | 4.58x | $39.96 | $3.0M | 269.3K | 75 |
| 2020 | $48.25 | $12.31 | 3.92x | $35.94 | $4.6M | 371.5K | 73 |
| 2021 | $52.51 | $13.14 | 4.00x | $39.37 | $4.4M | 337.6K | 70 |
| 2022 | $43.30 | $9.49 | 4.56x | $33.81 | $3.4M | 354.5K | 74 |
| 2023 | $46.39 | $11.08 | 4.19x | $35.31 | $3.4M | 310.1K | 68 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 119.2K | $4.9M | $40.80 | 2.89x |
| J9299 | Injection, nivolumab, 1 mg | 160.9K | $3.5M | $21.85 | 2.94x |
| J9310 | Injection, rituximab, 100 mg | 5.1K | $3.1M | $612.44 | 2.31x |
| J9035 | Injection, bevacizumab, 10 mg | 36.7K | $2.0M | $55.58 | 2.43x |
| J2505 | Injection, pegfilgrastim, 6 mg | 588 | $1.8M | $3.1K | 3.00x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 19.5K | $1.5M | $78.29 | 3.81x |
| J0897 | Injection, denosumab, 1 mg | 80.0K | $1.2M | $15.51 | 2.92x |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 15.9K | $1.2M | $74.31 | 2.36x |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | 7.7K | $994.2K | $129.45 | 2.34x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 17.8K | $921.6K | $51.89 | 3.91x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 9.2K | $859.9K | $93.84 | 7.59x |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 18.2K | $856.3K | $47.12 | 4.48x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 69.6K | $640.4K | $9.20 | 3.35x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 15.8K | $616.3K | $38.91 | 4.34x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 74.3K | $608.7K | $8.19 | 4.87x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 64.9K | $582.9K | $8.98 | 3.55x |
| J9022 | Injection, atezolizumab, 10 mg | 9.3K | $580.9K | $62.63 | 3.00x |
| J9312 | Injection, rituximab, 10 mg | 6.7K | $494.8K | $73.52 | 3.02x |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 7.8K | $420.0K | $53.85 | 2.74x |
| 80053 | Blood test, comprehensive group of blood chemicals | 42.7K | $405.0K | $9.49 | 4.43x |
This provider submits charges 4.1 times higher than what Medicare actually pays.
A markup ratio of 4.1x means for every $100 Medicare pays, this provider initially charges $410. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in AR for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Kamal Patel, M.D. | Little Rock, AR | $58.7M | ⚠️ Flagged |
| Balagopalan Nair, M.D. | Little Rock, AR | $54.5M | ⚠️ Flagged |
| Eric Schaefer, M.D. | Fayetteville, AR | $35.5M | ✓ Clear |
| Thomas Sneed, M.D. | Little Rock, AR | $34.7M | ✓ Clear |
| Gregory Oakhill, M.D. | Fayetteville, AR | $34.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data